Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Food Facilities, 2159-2162 [2022-00561]
Download as PDF
2159
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the February 1, 2022
ACD meeting must submit a request by
visiting https://www.cdc.gov/about/
advisory-committee-director/meetings
no later than 11:59 p.m., EST, January
24, 2022, according to the instructions
provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by January 28, 2022. To accommodate
the significant interest in participation
in the oral public comment session of
ACD meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–00565 Filed 1–12–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Head Start Program
Information Report (OMB #0970–0427)
Office of Head Start,
Administration for Children and
Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
Head Start (OHS) is requesting a 3-year
extension of the Head Start Program
Information Report (PIR), Monthly
Enrollment reporting instrument, and
Center Locations and Contacts
instrument (OMB #0970–0427,
expiration 4/30/2022). OHS has made
updates to these instruments, as
described below.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Description: OHS is requesting an
extension, with changes, of the Head
Start PIR information collection
authority. The following instruments are
included in this information collection:
(1) PIR, (2) Monthly Enrollment, and (3)
Center Locations and Contacts. The PIR
is used for federal program management
purposes including to promote decisionmaking using data, is a major source of
information used to respond to
Congressional and public inquiries
about Head Start programs, and is used
often by researchers. Monthly
enrollment reporting supports oversight
activities related to promoting full
enrollment of programs. Center
locations and contact reporting is used
to help parents locate a program in their
community. In general, these
information collections together create
key administrative datasets to support
administration of the program. The
proposed changes include new
questions on the PIR to collect
information on collaboration activities
with Part C agencies and the average
benefits provided to certain education
staff as part of their compensation.
Additionally, new questions were added
to the centers reporting to capture
participation in a local or state Quality
Rating Improvement System and
licensing status for each center. Lastly,
minor changes were made to these
instruments for clarification purposes.
Respondents: Head Start Grant
Recipients.
ANNUAL BURDEN ESTIMATES
Annual
number of
respondents
Instrument
jspears on DSK121TN23PROD with NOTICES1
Head Start PIR ................................................................................................
Monthly Enrollment ..........................................................................................
Center Locations and Contacts .......................................................................
Estimated Total Annual Burden
Hours: 11,760.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
VerDate Sep<11>2014
18:18 Jan 12, 2022
Jkt 256001
Annual
number of
responses per
respondent
1,600
1,600
1,600
Average
burden hours
per response
2.25
27
15
Annual
burden hours
1
0.05
0.25
3,600
2,160
6,000
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 9801 et seq.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Mary B. Jones,
ACF/OPRE Certifying Officer.
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Registration of
Food Facilities
[FR Doc. 2022–00502 Filed 1–12–22; 8:45 am]
BILLING CODE 4184–40–P
PO 00000
Food and Drug Administration
[Docket No. FDA–2021–N–1302]
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Frm 00034
Fmt 4703
Sfmt 4703
E:\FR\FM\13JAN1.SGM
Notice.
13JAN1
2160
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of the Agency’s
regulations that require registration for
domestic and foreign facilities that
manufacture, process, pack, or hold
food for human or animal consumption
in the United States.
DATES: Submit either electronic or
written comments on the collection of
information by March 14, 2022.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before March 14,
2022. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of March 14, 2022. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
VerDate Sep<11>2014
18:18 Jan 12, 2022
Jkt 256001
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2021–N–1302 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Registration of Food Facilities.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between
9 a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\13JAN1.SGM
13JAN1
2161
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
Registration of Food Facilities
OMB Control Number 0910–0502—
Extension
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (the Bioterrorism
Act) amended the Federal Food, Drug,
and Cosmetic Act (FD&C Act), to
require, among other things, domestic
and foreign facilities that manufacture,
process, pack, or hold food for human
or animal consumption in the United
States to register with FDA. Sections
1.230 to 1.235 of our regulations (21
CFR 1.230 to 1.235) set forth the
requirements for the registration of food
facilities. Information provided to us
under these regulations helps us to
quickly notify the facilities that might
be affected by a deliberate or accidental
contamination of the food supply. In
addition, data collected through
registration is used to support FDA
enforcement activities and to screen
imported food shipments.
Advance notice of imported food
allows FDA, with the support of the
Bureau of Customs and Border
Protection, to target import inspections
more effectively and help protect the
nation’s food supply against terrorist
acts and other public health
emergencies. If a facility is not
registered or the registration for a
facility is not updated when necessary,
we may not be able to contact the
facility and may not be able to target
import inspections effectively in case of
a known or potential threat to the food
supply or other food-related emergency,
putting consumers at risk of consuming
hazardous food products that could
cause serious adverse health
consequences or death.
To assist respondents of the
information collection we developed the
following forms. Each facility that
manufactures, processes, packs, or holds
food for human or animal consumption
in the United States must register with
FDA using Form FDA 3537 entitled
‘‘Food Facility Registration’’ (§ 1.231),
unless exempt under 21 CFR 1.226 from
the requirement to register. To cancel a
registration, respondents must use Form
FDA 3537a entitled ‘‘Cancellation of
Food Facility Registration’’ (§ 1.235).
The terms ‘‘Form FDA 3537’’ and ‘‘Form
FDA 3537a’’ refer to both the paper
version of each form and the electronic
system known as the Food Facility
Registration Module, which is available
at https://www.access.fda.gov.
Registrations, updates, and
cancellations are required to be
submitted electronically. Domestic
facilities are required to register whether
or not food from the facility enters
interstate commerce. Foreign facilities
that manufacture, process, pack, or hold
food also are required to register unless
food from that facility undergoes further
processing (including packaging) by
another foreign facility outside the
United States. However, if the further
manufacturing/processing conducted by
the subsequent facility consists of
adding labeling or any similar activity of
a de minimis nature, the former facility
is required to register. In addition to the
initial registration requirements, a
facility is required to submit timely
updates within 60 days of a change to
any required information on its
registration form, using Form FDA 3537
(§ 1.234), and to cancel its registration
when the facility ceases to operate or is
sold to new owners or ceases to
manufacture, process, pack, or hold
food for consumption in the United
States, using Form FDA 3537a (§ 1.235).
Registration is one of several tools
under the Bioterrorism Act that enables
us to act quickly in responding to a
threatened or actual bioterrorist attack
on the U.S. food supply or other foodrelated emergency. Further, in the event
of an outbreak of foodborne illness, the
information provided helps us
determine the source and cause of the
event and enables us to quickly notify
food facilities that might be affected by
an outbreak, terrorist attack, or other
emergency. Finally, the registration
requirements enable us to quickly
identify and remove from commerce an
article of food for which there is a
reasonable probability that the use of, or
exposure to, such article of food will
cause serious adverse health
consequences or death to humans or
animals.
Description of Respondents:
Respondents to this collection of
information are owners, operators, or
agents in charge of domestic or foreign
facilities that manufacture, process,
pack, or hold food for human or animal
consumption in the United States.
We estimate the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity; 21 CFR section
Total annual
responses
Average
burden per
response
Total
New domestic facility registration; 1.230–1.233 ..................
New foreign facility registration; 1.230–1.233 .....................
Updates; 1.234 .....................................................................
Cancellations; 1.235 ............................................................
Biennial renewals; 1.235 ......................................................
3rd party registration verification .........................................
U.S. Agent verification .........................................................
9,795
13,697
53,836
6,390
97,883
41,256
57,070
1
1
1
1
1
1
1
9,795
13,697
53,836
6,390
97,883
41,256
57,070
2.7
8.7
1.2
1
0.38
0.25
0.25
26,447
119,164
64,603
6,390
37,196
10,314
14,268
Total ..............................................................................
........................
........................
279,927
........................
278,382
1 There
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Sep<11>2014
19:23 Jan 12, 2022
Jkt 256001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\13JAN1.SGM
13JAN1
2162
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
Dated: January 4, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–00561 Filed 1–12–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0414]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Manufactured
Food Regulatory Program Standards
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of the
Manufactured Food Regulatory Program
Standards.
DATES: Submit either electronic or
written comments on the collection of
information by March 14, 2022.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before March 14,
2022. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of March 14, 2022. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
jspears on DSK121TN23PROD with NOTICES1
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
VerDate Sep<11>2014
19:23 Jan 12, 2022
Jkt 256001
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–N–0414 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Manufactured Food Regulatory Program
Standards.’’ Received comments, those
filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Rachel Showalter, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 240–994–7399, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Pages 2159-2162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00561]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2021-N-1302]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Registration of Food Facilities
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 2160]]
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the information collection provisions of
the Agency's regulations that require registration for domestic and
foreign facilities that manufacture, process, pack, or hold food for
human or animal consumption in the United States.
DATES: Submit either electronic or written comments on the collection
of information by March 14, 2022.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before March 14, 2022. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of March 14, 2022. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2021-N-1302 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Registration of Food
Facilities.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-5733,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
[[Page 2161]]
Registration of Food Facilities
OMB Control Number 0910-0502--Extension
The Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 (the Bioterrorism Act) amended the Federal Food,
Drug, and Cosmetic Act (FD&C Act), to require, among other things,
domestic and foreign facilities that manufacture, process, pack, or
hold food for human or animal consumption in the United States to
register with FDA. Sections 1.230 to 1.235 of our regulations (21 CFR
1.230 to 1.235) set forth the requirements for the registration of food
facilities. Information provided to us under these regulations helps us
to quickly notify the facilities that might be affected by a deliberate
or accidental contamination of the food supply. In addition, data
collected through registration is used to support FDA enforcement
activities and to screen imported food shipments.
Advance notice of imported food allows FDA, with the support of the
Bureau of Customs and Border Protection, to target import inspections
more effectively and help protect the nation's food supply against
terrorist acts and other public health emergencies. If a facility is
not registered or the registration for a facility is not updated when
necessary, we may not be able to contact the facility and may not be
able to target import inspections effectively in case of a known or
potential threat to the food supply or other food-related emergency,
putting consumers at risk of consuming hazardous food products that
could cause serious adverse health consequences or death.
To assist respondents of the information collection we developed
the following forms. Each facility that manufactures, processes, packs,
or holds food for human or animal consumption in the United States must
register with FDA using Form FDA 3537 entitled ``Food Facility
Registration'' (Sec. 1.231), unless exempt under 21 CFR 1.226 from the
requirement to register. To cancel a registration, respondents must use
Form FDA 3537a entitled ``Cancellation of Food Facility Registration''
(Sec. 1.235). The terms ``Form FDA 3537'' and ``Form FDA 3537a'' refer
to both the paper version of each form and the electronic system known
as the Food Facility Registration Module, which is available at https://www.access.fda.gov. Registrations, updates, and cancellations are
required to be submitted electronically. Domestic facilities are
required to register whether or not food from the facility enters
interstate commerce. Foreign facilities that manufacture, process,
pack, or hold food also are required to register unless food from that
facility undergoes further processing (including packaging) by another
foreign facility outside the United States. However, if the further
manufacturing/processing conducted by the subsequent facility consists
of adding labeling or any similar activity of a de minimis nature, the
former facility is required to register. In addition to the initial
registration requirements, a facility is required to submit timely
updates within 60 days of a change to any required information on its
registration form, using Form FDA 3537 (Sec. 1.234), and to cancel its
registration when the facility ceases to operate or is sold to new
owners or ceases to manufacture, process, pack, or hold food for
consumption in the United States, using Form FDA 3537a (Sec. 1.235).
Registration is one of several tools under the Bioterrorism Act
that enables us to act quickly in responding to a threatened or actual
bioterrorist attack on the U.S. food supply or other food-related
emergency. Further, in the event of an outbreak of foodborne illness,
the information provided helps us determine the source and cause of the
event and enables us to quickly notify food facilities that might be
affected by an outbreak, terrorist attack, or other emergency. Finally,
the registration requirements enable us to quickly identify and remove
from commerce an article of food for which there is a reasonable
probability that the use of, or exposure to, such article of food will
cause serious adverse health consequences or death to humans or
animals.
Description of Respondents: Respondents to this collection of
information are owners, operators, or agents in charge of domestic or
foreign facilities that manufacture, process, pack, or hold food for
human or animal consumption in the United States.
We estimate the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Activity; 21 CFR section Number of responses per Total annual Average burden Total
respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
New domestic facility 9,795 1 9,795 2.7 26,447
registration; 1.230-1.233......
New foreign facility 13,697 1 13,697 8.7 119,164
registration; 1.230-1.233......
Updates; 1.234.................. 53,836 1 53,836 1.2 64,603
Cancellations; 1.235............ 6,390 1 6,390 1 6,390
Biennial renewals; 1.235........ 97,883 1 97,883 0.38 37,196
3rd party registration 41,256 1 41,256 0.25 10,314
verification...................
U.S. Agent verification......... 57,070 1 57,070 0.25 14,268
-------------------------------------------------------------------------------
Total....................... .............. .............. 279,927 .............. 278,382
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
[[Page 2162]]
Based on a review of the information collection since our last
request for OMB approval, we have made no adjustments to our burden
estimate.
Dated: January 4, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-00561 Filed 1-12-22; 8:45 am]
BILLING CODE 4164-01-P